Comorbidities and public health conditions in haemophilia are receiving increasing attention. Aims: To analyse the prevalence of comorbidities and mortality in people with haemophilia (PwH) compared to...
Lire la suite

There are few data on healthcare resource use and related costs of French haemophilia A (HA) and B (HB) patients. Aims: This study aimed to describe the profile of HA and HB patients, current disease management,...
Lire la suite

The development of factor VIII inhibitors is a significant complication of hemophilia A, increasing the risk of bleeding and resulting in high morbidity. Recurrent joint bleeds lead to severe arthropathy...
Lire la suite

Patients with severe haemophilia A (HA) with no family history of haemophilia will be diagnosed upon their first bleeding event. Methods: Herein, we studied the effects of lack of family history in HA and the subsequent delay of diagnosis on bleeding pattern and early treatment, as well as on the risk of inhibitor development. For this purpose, data on 1237 severe HA patients with known family history (“positive” or “negative”),...
Lire la suite